Development Document for Interim Final Effluent Limitations Guidelines and Proposed New Source Performance Standards for the Pharmaceutical Manufacturing Point Source Category.
This document presents the findings of a study of the pharmaceutical manufacturing point source category fo the purpose of developing effluent limitations and guidelines for existing point sources plus standards of performance and pretreatment standards for existing and new sources, to implement Sections 301(b), 301(c), 304(b), 304(c), 306(b), 306(c), 307(b) and 307(c) of the Federal Water Pollution Control Act, as amended (33 U.S.C. 1251, 1311, 1314(b), 1314(c), 1316(b), 1317(b) and 1317(c), 86 Stat. 816 et. seq.) (the "Act").
|Office of Water|
|Effluent Guidelines Division|
|Office of Water and Hazardous Materials|
|Vitalis, Joseph S.; Jett, George M.|
|Background Cost-Related Document|